LAS VEGAS Rimini Street, Inc. (Nasdaq: RMNI), a leading global provider of enterprise software support and innovative solutions, announced today its collaboration with Apsen Farmacutica, a Brazilian pharmaceutical manufacturer. The partnership was unveiled during the annual Knowledge 2025 event hosted by ServiceNow, where Rimini Street aims to showcase its vision for the next generation of workflow efficiencies across enterprises.
Rimini Street, which specializes in third-party support for Oracle, SAP, and VMware software, faces a challenging market landscape. In the first quarter of 2025, the company reported a revenue decrease of 2.17% compared to the same period last year. This decline stands in stark contrast to an impressive revenue growth of 163.05% observed among most of its competitors during the same timeframe.
Despite the drop in revenue, Rimini Street demonstrated higher profitability than its rivals, achieving a net margin of 3.24%. The company s net income for Q1 2025 grew significantly, up 154.37% year-over-year, although this increase pales in comparison to competitors income growth, which reached an extraordinary 597.12%.
Additionally, Rimini Street s market share has also seen a decline, decreasing to 0.08% in Q1 2025 from 0.09% in Q4 2024. This reduction translates to maintaining just 0.08% market share over the past 12 months. The company s commitment to innovate and adapt in the face of these challenges will be crucial as it works to implement transformative solutions in collaboration with Apsen Farmacutica, ultimately striving to enhance efficiencies in enterprise workflows.
As Rimini Street aims to innovate in a competitive landscape, its partnership with Apsen Farmacutica signifies a strategic move to leverage existing strengths while navigating the hurdles presented by market dynamics.
Comments